Base on the number of gestation age-matched healthy controls in our cohort, we selected four gestation age-matched healthy controls for MA, FGR and PE. As the number of gestation age-matched healthy controls was limited by 267 GDM cases, we selected three controls for each GDM case. The gestational age of four pregnancy complications and their corresponding controls were well matched in four cohorts ( Supplemental Table S1 ; p > 0.05, Mann-Whiney U test). According to the time of sample collection and the sample size, the samples collected from Nanfang Hospital were divided into two cohorts, including training cohort (70% of samples) and internal cohort (30% of samples). The samples involved in The Third Affiliated Hospital of Sun Yat-sen University (SYSU) and Cangzhou People's Hospital were taken as external cohort-1 and external cohort-2, respectively. As some control samples were used in more than one pregnancy complication prediction, the number of total control is less than the sum control number for each pregnancy complication.
Isolation of cfDNA and whole-genome sequencing
Maternal blood was collected using a cfDNA BCT tube (Streck, USA). Cell-free plasma DNA (cfDNA) was extracted from a plasma sample using the QIAamp DNA Blood Mini kit (Qiagen, German) by following the manufacturer's instructions. DNA concentration and integration were measured using Qubit (ThermoFisher Scientific, USA) and Agilent Bioanalyzer 2100 (Agilent Technologies, USA). DNA was eluted in 50 µL AE buffer and stored at −20°C. For Life platform, libraries were prepared using the Ion Torrent Ampliseq 2.0 kit (ThermoFisher Scientific), according to the manufacturer's instructions. Samples were barcoded and quantified by qPCR using the Ion Xpress Barcode Adapter and the Ion Library TaqMan quantitation kit (ThermoFisher Scientific), respectively. Sequencing libraries were then sequenced on Ion Proton System on a P1 chip. For illumina platform, the DNA libraries were prepared using the TruSeq DNA Sample Prep reagents (Illumina, USA). After quantification on the LabChip GX microfluidic platform (Perkin-Elmer), the libraries were then sequenced using NextSeq. DNA sequencing was performed at a depth of 0.3 average coverage.
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Supplemental Figures
Supplemental Figure 1 . Promoter read depth patterns of highly and lowly expressed genes for pregnancy complications. Mean expression levels of the 500 most-(Top500, red) and least-expressed (Bottom500, blue) genes in the placenta and their promoter read coverages of the cfDNA derived from pregnancies with PE (a), GDM (b) and FGR (c). Mean expression levels of the 500 most-and least-expressed genes in blood cells and their promoter read coverages of the cfDNA derived from pregnancies with PE (d) and GDM (e). FGR = fetal growth restriction. GDM = gestational diabetes mellitus. PE = preeclampsia 
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Supplemental Table S1 . Clinical characteristics of study pregnancies in four cohorts In these equations, the gene coverage around TSSs ranging from -1 KB to +1 KB were substituted with the discretized value "one" when the level of each gene was larger than the corresponding cut-off (see Supplemental Table S8 -S11); otherwise, it was substituted with the discretized value "zero". If the result of Logit p was larger than the corresponding threshold, the detected subject was predicted as pregnancy complications (MA, GFR, GDM, and PE); otherwise as non-obstetrical syndromes. MA = macrosomia. FGR = fetal growth restriction. GDM = gestational diabetes mellitus. PE = preeclampsia. Supplemental Table S14 . The performance of the optimal classifiers based on promoter profiling of tissue-specific genes 
